Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.
The Jafar Family Fund for Multiple Myeloma Research at Dana-Farber Cancer Institute was established in 2017 to help accelerate research of new therapies for patients and families facing this disease. The fund is managed by Paul Richardson, MD, RJ Corman Professor of Medicine, Harvard Medical School, and Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center at Dana-Farber. All gifts to the Jafar Family Fund for Multiple Myeloma Research will help Dr. Richardson and his team lead clinical trials of promising therapies and support their tireless efforts to expand the arsenal of treatment options against this difficult disease.